Technological And Cultural Impediments Slow Electronic NIH Grant Submission

Computer compatibility and investigator reluctance blamed for the long delay in agency's move into the digital age. The Internal Revenue Service began accepting electronic transmission of federal income tax forms in 1986. This time-saving option has become quite popular, and by 1994 was used by some 14 million taxpayers. Yet at the National Institutes of Health--which funds some of the most scientifically sophisticated researchers in the world--grant proposals are, for the most part, still bei

Written byLiane Rief-leherer
| 11 min read

Register for free to listen to this article
Listen with Speechify
0:00
11:00
Share


Computer compatibility and investigator reluctance blamed for the long delay in agency's move into the digital age.
The Internal Revenue Service began accepting electronic transmission of federal income tax forms in 1986. This time-saving option has become quite popular, and by 1994 was used by some 14 million taxpayers. Yet at the National Institutes of Health--which funds some of the most scientifically sophisticated researchers in the world--grant proposals are, for the most part, still being submitted and processed on paper. Why is NIH taking so long to move into the electronic age?

The answer, report researchers and NIH officials, is, in part, that electronic submission of a complete government grant application is fraught with difficulties. In addition to the technical problems that have been encountered in attempts to produce a paperless grant application submission process--such as incompatibilities among computer systems--there are human factors. For example, some investigators are too busy ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies